Progenity, Inc. (PROG)
| Market Cap | 447.04M |
| Revenue (ttm) | 39.45M |
| Net Income (ttm) | -230.07M |
| Shares Out | 163.75M |
| EPS (ttm) | -3.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 37,413,538 |
| Open | 2.99 |
| Previous Close | 2.82 |
| Day's Range | 2.64 - 3.05 |
| 52-Week Range | 0.66 - 7.86 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 3.00 (+9.9%) |
| Earnings Date | Nov 10, 2021 |
About PROG
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. It offers Innatal, a noninvasive prenatal screening test offered to women early in pregnancy to screen for chromosome abnormalities, such as down syndrome, trisomy 18, trisomy 13, and sex chromosome disorders through the analysis of cell-free DNA; Preparent that screens for carrier status of hereditary diseases prior to or early in pregnancy; and Riscover, a hereditary cancer screen that analyzes 31 genes associated wi...
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for Progenity stock is "Strong Buy." The 12-month stock price forecast is 3.00, which is an increase of 9.89% from the latest price.
News
4 Top Penny Stocks To Buy For Under $5
Top penny stocks traders decided to buy today but are they worth the risk? The post 4 Top Penny Stocks To Buy For Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock...
Progenity Announces New Patent for Single-Molecule Detection Technology
SAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a new p...
Why Shares of Progenity Are Down More Than 11% on Wednesday
The biotech has given investors a bumpy ride this month.
Capital Raises Add Confidence to Fast-Moving Biotech Progenity
Unique delivery of GI-disease treatments -- along with multiple liquidity infusions -- should help to ease the concerns of PROG stock holders. The post Capital Raises Add Confidence to Fast-Moving Biote...
7 Penny Stocks to Sell Before Year End
Before you close the books on 2021, if you hold a position in any of these seven penny stocks to sell, make sure to make your exit. Camber Energy (NYSEAMERICAN:CEI) Clover Health (NASDAQ:CLOV) Express (...
Hot Penny Stocks Today: Why Is PROG Stock Moving?
Shares of penny stock PROG are on the move and here's what's going on. The post Hot Penny Stocks Today: Why Is PROG Stock Moving?
Progenity Strengthens its Liquidity Position
Company received more than $44 million in warrant exercises since August 2021.
Best Penny Stocks To Buy For A Short Squeeze? 5 To Watch Today
Short squeeze penny stocks to watch today. The post Best Penny Stocks To Buy For A Short Squeeze?
5 Short Squeeze Candidates For The Week: AGC SPAC Rejoins, Digital Ally, Tattooed Chef Join Leaderboard
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) or AMC Entertainment Holdings Inc (NYSE: AMC). A short squeeze can occur wh...
Top Penny Stocks to Add to Your Watchlist in Late November
Here's three penny stocks to add to your watchlist right now The post Top Penny Stocks to Add to Your Watchlist in Late November appeared first on Penny Stocks to Buy, Picks, News and Information | Penn...
Investing in Penny Stocks? 3 That Could Be Worth Watching Right Now
Thinking of investing in penny stocks? Here's three to check out The post Investing in Penny Stocks?
Progenity Has Too Many Problems, Not Enough Money?
One of the many recent IPOs since the Covid-19 pandemic, PROG stock has encountered numerous setbacks to be a comfortable ride. With their partnership with Avero Diagnotics, management is currently refo...
4 New Patents Add to Progenity's Appeal
PROG stock has had its fair share of ups and downs. With a major executive-level change, however, Progenity looked poised for progress.
Why Progenity Stock Is Up More Than 34% Tuesday
Shares of the biotech stock rose more than $1.50 per share Tuesday morning.
PROG Stock Alert: What Is Going on With Progenity Today?
Popular short play Progenity is enjoying a good week. PROG stock is gaining as investors continue to bet against short sellers.
With Progenity, What Is Pumped Will Be Dumped
Progenity came public as a genetic testing company in 2020, then closed the lab and is doing early-stage clinical trials. The post With Progenity, What Is Pumped Will Be Dumped appeared first on Investo...
5 Penny Stocks To Buy According To Analysts With Targets Up To 156%
Penny stocks to buy right now according to analysts. The post 5 Penny Stocks To Buy According To Analysts With Targets Up To 156% appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...
Progenity: Don't Bet on This Biotech Firm Yet
PROG Stock IPOed in 2020 to develop a genetic testing business. Progenity has now shut that business down, leaving shareholders in a lurch.
Best Penny Stocks To Buy? 5 Short Squeeze Stocks To Watch Now
Short squeeze penny stocks to watch right now. The post Best Penny Stocks To Buy?
5 Short Squeeze Candidates To Watch: Huadi Tops List, Altimeter Group And Bit Digital Rejoin Leaderboard
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE:GME) or AMC Entertainment Holdings Inc (NYSE:AMC). A short squeeze can occur when...
Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at the...
I Almost Confused Progenity With Progressive Insurance
Only a meme stock could garner the kind of investor interest PROG stock has with no chance of returning to 2020 revenue levels anytime soon. The post I Almost Confused Progenity With Progressive Insuran...
Progenity Is a Risky Bet Due to Its Restructuring Gamble
Progenity's plan to ditch most of its current portfolio and double down on R&D may come back to bite it later. Avoid PROG stock for now.
Say Goodbye — Not Good Buy — to the Progenity Short Squeeze
Progenity may be onto something big, but today it's just a meme stock. Following earnings, PROG stock is in trouble.
3 ‘Must Watch' Penny Stocks in Mid-November 2021
Making a penny stocks watchlist? Check these three out The post 3 ‘Must Watch' Penny Stocks in Mid-November 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.